Date & Time :  22 June 2026 | 15:00–16:00 CEST | Online

 

 

 

The webinar aims to provide insights into how and why patients decide to undergo reirradiation, how they weigh potential risks and benefits and their views on participation in clinical trials

 

Moderators

• Ane Appelt, Professor of Clinical Medical Physics, Rigshospitalet & Technical University of Denmark, Copenhagen, Denmark 
• Finbar Slevin, Associate Professor of Clinical Oncology, University of Leeds and Leeds Cancer Centre, Leeds, UK

 

Panellists

• Rebecca Muirhead, Consultant in Clinical Oncology, Oxford University Hospitals NHS Foundation Trust, UK
• Robert Rulach, Consultant in Clinical Oncology, Oxford University Hospitals NHS Foundation Trust, UK
• Finbar Slevin, Associate Professor of Clinical Oncology, University of Leeds and Leeds Cancer Centre, Leeds, UK

 

Programme

• 15:00-15:05 |  Introductions (Ane Appelt, Finbar Slevin)
• 15:05-15:15 | Rebecca Muirhead - Shared decision making for reirradiation
• 15:15-15:30 | Rob Rulach - Thoracic re-irradiation: the patient's perspective
• 15:30-15:35 | Q&A
• 15:35-15:50 | Finbar Slevin- Patient perspectives regarding reirradiation for recurrent cancer: insights from the STA:RTUPP project
• 15:50-15:55 | Q&A
• 15:55-16:00 | Close

 

Key Learning Objectives

• To understand how patients might weigh regarding risks and benefits of reirradiation
• To understand patient perspectives regarding advanced technologies for reirradiation
• To understand how patient perspectives could shape future study design

 

7. Resources / Reading References

Slevin F, et al. Patient perspectives on reirradiation for recurrent cancer, to inform future clinical trial design. Clinical Oncology, 2026. 104201